Testosterone therapy labels and limits may change under FDA proposal

MedicalXpress | يون 23, 2026

The U.S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone replacement therapy products to reflect newer clinical evidence.